三个马格里布国家的药品管理入口协议:付款人和供应商的前景
Hajer Dahmani1, Leila Achour2,3,
1Department of Pharmaceutical Quality Assessment, National Laboratory of Control of Medicines, Tunis 1006, Tunisia.
管理入境协议 (MEA) 正在北非出现, 但面临法律框架和预算限制等挑战. 基于财务的协议 (FBA) 是获得新药的第一步.
科学领域:
- 健康经济学
- 制药政策
- 进入市场
背景情况:
- 管理入口协议 (MEA) 越来越多地被认为是制药市场中平衡创新和可负担性的工具.
- 北非国家正在探索MEA以管理获得新的高成本药物.
研究的目的:
- 描述阿尔及利亚,摩洛哥和突尼斯实施MEA的经验和挑战.
- 确定使用的MEA类型及其采用障碍.
- 收集这些国家制药行业的重要决策者的见解.
主要方法:
- 与阿尔及利亚,摩洛哥和突尼斯的公共和私营制药部门的15位主要决策者进行了在线采访.
- 采访时间为2021年3月至2023年12月.
- 一个问卷记录了经验,MEA类型和实施挑战.
主要成果:
- 只有突尼斯的受访者报告了有经验的MEA,特别是涉及折扣的基于金融的协议 (FBA).
- 受访者认为缺乏法律框架和新药预算不足是实施的主要障碍.
- 所有参与者都高度意识到需要针对昂贵药物的定制合同.
结论:
- 预计北非的MEA将增加,以改善补偿和获得高价创新药物的机会.
- 建议加强定价,报销流程和医疗技术评估 (HTA).
- 建议采用FBA作为MEA实施的务实初步战略.
更多相关视频
06:04Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Absorption Mechanism: Passive Membrane Transport
